Drug
Ortho Tri-Cyclen®
Ortho Tri-Cyclen® is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_1
3
75%
Phase Distribution
3
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 1
Trials by Phase
Phase 13 (75.0%)
N/A1 (25.0%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives
NCT00775190
completedphase_1
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT00983957
completedphase_1
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
NCT00549666
completedphase_1
Drug Interaction Oral Contraceptive Pill (OCP)
NCT01063023
Clinical Trials (4)
Showing 4 of 4 trials
NCT00775190Not Applicable
Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives
NCT00983957Phase 1
Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects
NCT00549666Phase 1
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
NCT01063023Phase 1
Drug Interaction Oral Contraceptive Pill (OCP)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4